Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
December 26, 2005
- NEW PRODUCTS
December 26, 2005
- Both Patients and Medical Professionals Need Education about Mammography: JSBH Seminar
December 26, 2005
- (Proposed) Outline of the FY2006 NHI Pricing System Reform
December 26, 2005
- Company Financial Support Encourages Mammography Screening: J&J
December 26, 2005
- Stop the press!
December 26, 2005
- SURVEY 3 articles
December 26, 2005
- Discussions to Continue on Pricing of Long-listed Drugs, Frequency of Price Revisions
December 26, 2005
- R&D NEWS IN BRIEF
December 26, 2005
- JGPMA to Submit Petition on Full Specifications for Generics
December 26, 2005
- Outline of FY2006 NHI Pricing System Reform Approved
December 26, 2005
- 13 New Kit Products Listed
December 26, 2005
- New R&D Tax Break System to Unify 2 Existing Systems
December 26, 2005
- REGULATORY NEWS IN BRIEF -1-
December 26, 2005
- Tyco Healthcare Supports Spread of Laparoscopic Surgery
December 19, 2005
- Pfizer Japan Discusses Restructuring with Labor Union
December 19, 2005
- Osaka Univ. to Develop Training Method for Laparoscopic Surgery
December 19, 2005
- Banyu to Reorganize, Cut 300 Jobs
December 19, 2005
- MEDICAL DEVICE NEWS IN BRIEF
December 19, 2005
- BUSINESS NEWS IN BRIEF
December 19, 2005
ページ
Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…